A standard Lipid Panel (Lipid Profile) measures four basic blood lipid parameters: Total Cholesterol, HDL-C, Triglycerides, and calculated LDL-C. While standard guidelines accept an LDL-C under 100 mg/dL, preventative longevity cardiology targets an LDL-C < 70 mg/dL (or < 55 mg/dL in high-risk individuals). Furthermore, the Triglyceride-to-HDL Ratio (< 1.5) serves as the single best standard marker of atherogenic small dense LDL particles and hepatic insulin resistance.
Cardiovascular disease remains the leading cause of mortality worldwide, responsible for 1 in every 3 deaths.
For decades, the Lipid Panel (Lipid Profile) has served as the frontline clinical screening tool to evaluate cardiovascular risk.
However, standard laboratory reference ranges are designed to detect acute pathology rather than optimize lifespan. A patient can have "normal" cholesterol numbers on a standard lab report while silently accumulating calcified plaque inside their coronary arteries.
What does each lipid marker measure, what are the true optimal longevity targets, and why is the Triglyceride-to-HDL ratio an essential metabolic indicator?
The 4 Core Biomarkers of the Standard Lipid Panel#
A standard lipid profile evaluates circulating fat-protein complexes in blood serum:
| Lipid Biomarker | Biological Function & Pathophysiology | Conventional Normal Range | Optimal Preventative Longevity Target |
|---|---|---|---|
| Total Cholesterol (TC) | Total concentration of cholesterol carried across all lipoprotein classes (HDL, LDL, VLDL). | < 200 mg/dL | 150 to 180 mg/dL (Context-dependent based on particle count). |
| Low-Density Lipoprotein (LDL-C) | Primary carrier of cholesterol to peripheral tissues; particles can penetrate the endothelial wall, oxidize, and initiate atherosclerosis. | < 100 mg/dL | < 70 mg/dL (Primary prevention) < 55 mg/dL (Known ASCVD / High risk). |
| High-Density Lipoprotein (HDL-C) | Facilitates reverse cholesterol transport, extracting excess cholesterol from peripheral macrophages and returning it to the liver. | > 40 mg/dL (M) > 50 mg/dL (F) | 50 to 70 mg/dL (Extremely high levels > 90 mg/dL can be dysfunctional). |
| Triglycerides (TG) | Circulating neutral fats stored in adipose tissue and packaged into VLDL by the liver for fuel delivery. | < 150 mg/dL | < 80 to 90 mg/dL (Reflects healthy hepatic insulin sensitivity). |
The Triglyceride-to-HDL Ratio: Unmasking Small Dense LDL#
Standard lipid panels measure the total weight of cholesterol inside LDL particles, but they do not reveal whether your LDL particles are large and buoyant (less harmful) or small, dense, and oxidized (highly atherogenic):
Triglyceride-to-HDL Ratio = Serum Triglycerides (mg/dL) / Serum HDL-C (mg/dL)
| TG / HDL Ratio | Clinical & Metabolic Interpretation | Cardiovascular Significance |
|---|---|---|
| < 1.0 (Optimal) | Pattern A LDL (Large, Buoyant): High insulin sensitivity, minimal endothelial inflammation. | Lowest risk of coronary plaque formation; optimal metabolic health. |
| 1.0 to 1.9 (Normal) | Balanced lipoprotein distribution. | Low to moderate risk. |
| 2.0 to 2.9 (Borderline) | Emerging hepatic insulin resistance and small dense LDL particles. | Mildly elevated risk; indicates need for carbohydrate moderation and Zone 2 exercise. |
| ≥ 3.0 (High Risk) | Pattern B LDL (Small, Dense): Severe hyperinsulinemia, hepatic steatosis, high atherogenic burden. | 3 to 4-fold increase in myocardial infarction risk, regardless of total LDL level. |
Non-HDL Cholesterol: The Overlooked Metric#
If your lab report does not measure advanced apolipoproteins, look at your Non-HDL Cholesterol:
Non-HDL Cholesterol = Total Cholesterol - HDL Cholesterol
- Why It Matters: Non-HDL cholesterol captures the combined cholesterol content of all atherogenic particles (LDL, VLDL, IDL, and Lipoprotein(a)).
- Longevity Target: Target a Non-HDL Cholesterol < 90 to 100 mg/dL (conventional guidelines accept < 130 mg/dL).
While moderate HDL (50–70 mg/dL) is protective, genetically or pathologically elevated HDL (> 90–100 mg/dL) often represents dysfunctional HDL that has lost its anti-inflammatory and reverse-transport capabilities.
To explore fasting requirements for cholesterol testing, read Fasting vs. Non-Fasting Lipid Panels Explained.
Track Your Health & Lipid Biomarkers with Meridian#
Monitoring your laboratory blood biomarkers over time gives you objective validation that your diet, exercise, and lifestyle habits are keeping your cardiovascular risk in optimal ranges.
Meridian is an offline personal health vault for iPhone designed to give you complete ownership of your medical diagnostic data.
- Instant Lab Report Extraction: Take a photo or upload a PDF of your Lipid Panel, Comprehensive Metabolic Panel, and advanced cardiac markers from Quest, Labcorp, or your clinic. Meridian extracts your biomarkers on-device using Apple VisionKit.
- Longitudinal Cardiovascular Trends: Track how your LDL-C, Triglycerides, Non-HDL, and Triglyceride/HDL ratio improve over years.
- 100% On-Device & Private: Protected by hardware AES-256 encryption and FaceID. Zero cloud servers. Zero data tracking.
Take control of your cardiovascular health and medical privacy today. Download Meridian on the App Store and keep your diagnostic records organized, private, and secure.